InnovAge Holding Corp.

INNV Healthcare Medical Care Facilities

InnovAge Holding Corp.’s revenue for fiscal 2026 (year ended June 2026) was $989.7 million, up 15.9% from fiscal 2025.

Revenue
+12.1%
EPS
+155.0%
Free cash flow
+622.8%
Total debt
−16.7%

Quarter to September 2026, against a year earlier

9.04 0.75 −7.66%
Market cap
$1.2B
P/E
124×
Fwd P/E
20.9×
Dividend yield
—
F-score
6/9
Altman Z
4.58
Beneish M
−3.10
Dividend safety
n/a
Jun '17 Jun '19 Jun '20 Jun '21 Jun '22 Jun '23 Jun '24 Jun '25 Jun '26
Piotroski F-Score
— — — 5 4 3 4 6 6
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — — 9.83 3.18 3.28 2.65 2.23 4.58
P/S ratio
— 4.64 4.64 4.13 0.85 1.48 0.90 0.59 1.62
Altman Z″-Score (non-manufacturers)
— 2.03 3.17 3.91 3.21 1.18 0.80 0.00 0.32
P/FCF ratio
— 141.37 141.37 0.00 0.00 0.00 0.00 21.57 31.73
Beneish M-Score
— — (2.82) (3.03) (2.45) (3.27) (1.45) (3.32) (3.10)
P/Operating CF
— 162.85 162.85 277.88 183.03 77.33 365.69 55.50 75.53
P/B ratio
— 0.00 0.00 7.73 1.75 3.37 2.47 2.10 6.73
EV/Sales
— 5.01 5.01 3.94 0.70 1.34 0.86 0.54 1.54
EV/EBITDA
— 113.77 113.77 2,478.95 49.32 0.00 0.00 0.00 62.08
EV/FCF
— 152.51 152.51 (100.09) (34.13) (141.15) (13.68) 19.90 30.05
Current Ratio
— 1.43 2.18 3.19 2.29 1.45 1.25 1.07 1.05
Net Debt/EBITDA
— 2.66 1.62 (121.57) (10.36) 2.73 6.52 3.94 (3.47)
Debt/Equity
— 2.37 2.01 0.24 0.24 0.27 0.28 0.28 0.24
ROE
— 22.35% 27.78% (19.60%) (1.92%) (12.70%) (7.36%) (11.76%) (1.06%)
ROA
— 10.78% 6.80% (9.34%) (1.20%) (7.24%) (3.83%) (5.64%) (0.47%)
ROIC
— 11.62% 15.18% (3.54%) (1.17%) (14.68%) (5.73%) (9.34%) 1.06%
Return on Tangible Assets
— 14.27% 13.63% (13.96%) (2.09%) (15.71%) (9.38%) (16.90%) (1.44%)
Average Days of Receivables
— 43.12 30.92 21.74 22.29 13.05 24.58 16.97 16.84
Earnings Yield
— (0.74%) (0.74%) (1.73%) (0.91%) (4.13%) (3.17%) (6.23%) (0.17%)
Free Cash Flow Yield
— 0.71% 0.71% (0.95%) (2.42%) (0.64%) (7.04%) 4.64% 3.15%
Free Cash Flow per Share
— 0.09 0.24 (0.22) (0.08) (0.02) (0.33) 0.20 0.40
Book value per Share
— 0.62 0.81 2.76 2.50 2.23 2.04 1.76 1.76
Free Cash Flow
— 11.42 32.15 (27.09) (10.94) (3.12) (44.81) 26.60 54.12
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 581.74
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026